{
  "ticker": "JNJ",
  "target_date": "2025-10-06",
  "actual_date": "2025-10-06",
  "collected_at": "2025-12-08T12:22:03.369736",
  "price": {
    "open": 186.81,
    "high": 188.72,
    "low": 186.19,
    "close": 186.97286987304688,
    "volume": 5806100,
    "change_1d_pct": -0.25,
    "change_7d_pct": 5.87,
    "change_30d_pct": 5.72
  },
  "technicals": {
    "rsi_14": 75.61,
    "sma_20": 178.44,
    "sma_50": 174.79,
    "macd": 3.255,
    "macd_signal": 2.263,
    "macd_histogram": 0.993,
    "bb_upper": 187.7,
    "bb_lower": 169.19,
    "price_vs_sma20_pct": 4.78,
    "price_vs_sma50_pct": 6.97,
    "volume_ratio": 0.67
  },
  "fundamentals": {
    "market_cap": 488002715648,
    "pe_ratio": 19.551159,
    "forward_pe": 19.10849,
    "price_to_book": 6.147753,
    "price_to_sales": 5.2958007,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.53,
    "pct_from_52w_low": 43.98
  },
  "macro": {
    "spy": {
      "price": 671.61,
      "change_1d_pct": 0.36,
      "change_7d_pct": 1.48
    },
    "vix": {
      "level": 16.37,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.16
    },
    "dollar_index": {
      "level": 98.11
    },
    "gold": {
      "price": 3948.5
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Top Analyst Reports for Microsoft, Amazon.com & Johnson & Johnson",
      "source": "Yahoo",
      "datetime": 1759784820,
      "summary": "Microsoft rides AI and cloud growth, Amazon leans on AWS and Prime, and Johnson & Johnson gains from strong pharma momentum despite patent risks.",
      "url": "https://finnhub.io/api/news?id=c22176a4e79964249f5be31b1a62a574487e75e93b8db41971189a324270a29a"
    },
    {
      "headline": "Bernstein Maintains Johnson & Johnson (JNJ) Market Perform Recommendation",
      "source": "Fintel",
      "datetime": 1759779530,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b85ddf9e7506baa415306d8de57d6d6b2243923750d826f48d0191b6a81582a0"
    },
    {
      "headline": "Earnings Are Coming. Wall Street Hopes Strong Profits Can Keep the Market Rally Going.",
      "source": "Yahoo",
      "datetime": 1759772580,
      "summary": "Third-quarter profit growth should be solid. Tech and AI will lead the way, but earnings momentum could broaden too.",
      "url": "https://finnhub.io/api/news?id=309a544838bb1c11a4b759cca0698a2c912510216becc69cfe7ee748d9cb94ca"
    },
    {
      "headline": "Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsight",
      "source": "Yahoo",
      "datetime": 1759770000,
      "summary": "The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional symptom-focused strategies toward therapies that specifically target fibrosis and immune modulation, addressing a significant unmet need. The development pipeline is varied, with prominent candidates including Mi",
      "url": "https://finnhub.io/api/news?id=3a96d673fad800ab7302636a8b19c3c5b521809503cde1f57b653700adb5158f"
    },
    {
      "headline": "My Top 5 Biotech Stocks Big Pharma Could Buy Next",
      "source": "SeekingAlpha",
      "datetime": 1759757340,
      "summary": "Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest to Big Pharma players.",
      "url": "https://finnhub.io/api/news?id=0615cc217ad0cd350a198a8133c50199b31af463e4f96ab378a062934e7cccc8"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}